Literature DB >> 106884

Fifth component of human complement: purification from plasma and polypeptide chain structure.

B F Tack, S C Morris, J W Prahl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106884     DOI: 10.1021/bi00575a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  30 in total

1.  Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.

Authors:  A P Dalmasso; G M Vercellotti; R J Fischel; R M Bolman; F H Bach; J L Platt
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

2.  Fifth component of complement (C5)-derived high-molecular-weight macrophage chemotactic factor in normal guinea pig serum.

Authors:  I Kukita; T Yamamoto; T Kawaguchi; T Kambara
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

3.  C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.

Authors:  H Kitamura; M Matsumoto; K Nagaki
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

4.  Prevention of immune precipitation by purified classical pathway complement components.

Authors:  J K Naama; A O Hamilton; A C Yeung-Laiwah; K Whaley
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

Review 5.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

6.  Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates.

Authors:  V Alvarez; E Coto; F Setién; S González-Roces; C López-Larrea
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.

Authors:  J O Minta; M B Urowitz; H A Smythe; D E Isenman
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

8.  The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.

Authors:  R G DiScipio
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

9.  The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.

Authors:  H Kitamura; M Tsuboi; K Nagaki
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

10.  Study on C3-like factor in the serum of a C3-deficient subject.

Authors:  H Kitamura; H Nishimukai; Y Sano; K Nagaki
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.